Guest guest Posted March 20, 2009 Report Share Posted March 20, 2009 Cvt-e002, A Polysaccharide From North American Ginseng (panax Quinquefolium) Reduces Allergic Immune Response And Development Of Airway Reactivity In A Mouse Model Of Asthma. CONCLUSION: CVT-E002 could be a potential immunomodulatory therapy for asthma. https://www.aaaai.org/members/annual_meeting/am2009/late_breaking_abstracts.pdf Alana Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.